Attitudes toward direct-to-consumer advertisements and online genetic testing among high-risk women participating in a hereditary cancer clinic

Journal of Health Communication

Volumn 16, Issue 6, 2011, Pages 607-628

  Perez, Giselle K ^a   Cruess, Dean G ^a   Cruess, Stacy ^a   Brewer, Molly ^b   Stroop, Jennifer ^b   Schwartz, Robin ^b   Greenstein, Robert ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAP PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ADULT; ADVERTIZING; AGED; ARTICLE; ATTITUDE; ATTITUDE TO HEALTH; CANCER CENTER; CHI SQUARE DISTRIBUTION; FAMILIAL CANCER; FEMALE; GENETIC SCREENING; GENETICS; HEALTH SURVEY; HUMAN; INTERNET; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; OVARY TUMOR; PATIENT PARTICIPATION; PATIENT SATISFACTION; PERCEPTION; PREVALENCE; PSYCHOLOGICAL ASPECT; RISK FACTOR; WOMEN'S HEALTH;

ADULT; ADVERTISING AS TOPIC; AGED; AGED, 80 AND OVER; ATTITUDE; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC TESTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; INTERNET; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; ONCOLOGY SERVICE, HOSPITAL; OVARIAN NEOPLASMS; PATIENT PARTICIPATION; PATIENT SATISFACTION; PREVALENCE; RISK FACTORS; SOCIAL PERCEPTION; STATISTICS, NONPARAMETRIC; UBIQUITIN-PROTEIN LIGASES; WOMEN'S HEALTH; YOUNG ADULT;

EID: 79960725883     PISSN: 10810730     EISSN: 10870415     Source Type: Journal    
DOI: 10.1080/10810730.2011.551993     Document Type: Article

References (70)

1. American Cancer Society. (2008). Cancer facts and figures, 2008. Retrieved January 10, 2009, from http://209.135.47.118/downloads/STT/ 2008CAFFfinalsecured.pdf
2. An, S. (2007). Attitude toward direct-to-consumer advertising and drug inquiry intention: The moderating role of perceived knowledge. Journal of Health Communication, 12, 567-580. (Pubitemid 47347128)
3. Andersen, M. R., Bowen, D., Yasui, Y., & McTiernan, A. (2003). Awareness and concern about ovarian cancer among women at risk because of a family history of breast and ovarian cancer. American Journal of Obstetrician Gynecology, 189, S42-S47. (Pubitemid 37372575)
4. Andrykowski, M. A., Munn, R. K., & Studts, J. L. (1996). Interest in learning of personal genetic risk for cancer: A general population survey. Preventive Medicine, 25, 527-536. (Pubitemid 26315224)
5. Antoniou, A., Pharoah, P. D., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., et al. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. American Journal of Human Genetics, 72, 1117-1130. (Pubitemid 36530000)
6. Armstrong, K., Stopfer, J., Calzone, K., Fitzgerald, G., Coyne, J., & Weber, B. (2002). What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1=2 mutations. Genetic Testing, 6, 115-118.
7. Armstrong, K., Weber, B. L., Ubel, P. A., Guerra, C., & Schwartz, J. S. (2002). Interest in BRCA1=2 testing in a primary care population. Preventive Medicine, 34, 590-595. (Pubitemid 34971660)
8. Arora, N. K., & McHorney, C. A. (2000). Patient preferences for medical decision making: Who really wants to participate? Medical Care, 38, 335-341.
9. Bluman, L. G., Rimer, B. K., Sterba, K. R., Lancaster, J., Clark, S., Borstelmann, N., et al. (2003). Attitudes, knowledge, risk perceptions and decision-making among women with breast and=or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses. Psycho-Oncology, 12, 410-418.
10. Bottorff, J. L., Ratner, P. A., Richardson, C., Balneaves, L. G., McCullum, M., Hack, T., et al. (2002). Women's interest in genetic testing for breast cancer risk: The influence of sociodemographics and knowledge. Cancer Epidemiology, Biomarkers & Prevention, 11, 89-95. (Pubitemid 34118317)
11. Bowen, D. J., Helmes, A., Powers, D., Andersen, M. R., Burke, W., McTiernan, A., et al. (2003). Predicting breast cancer screening intentions and behavior with emotion and cognition. Journal of Social and Clinical Psychology, 22, 213-232. (Pubitemid 36630348)
12. Cameron, L. D., & Reeve, J. (2006). Risk perceptions, worry, and attitudes about genetic testing for breast cancer susceptibility. Psychology & Health, 21, 211-230. (Pubitemid 43663667)
13. Cappelli, M., Surh, L., Walker, M., Korneluk, Y., Humphreys, L., Verma, S., et al. (2001). Psychological and social predictors of decisions about genetic testing for breast cancer in high-risk women. Psychology, Health & Medicine, 6, 321-333. (Pubitemid 32705978)
14. Centers for Disease Control and Prevention. (2004). Genetic testing for breast and ovarian cancer susceptibility: Evaluating direct-to-consumer marketing-Atlanta. Denver, Raleigh, Durham, and Seattle, 2003. Morbidity and Mortality Weekly Report, 53, 603-605.
15. Claes, E., Evers-Kiebooms, G., Denayer, L., Decruyenaere, M., Boogaerts, A., Philippe, K., et al. (2005). Predictive genetic testing for hereditary breast and ovarian cancer: Psychological distress and illness representations 1 year following disclosure. Journal of Genetic Counseling, 14, 349-363. (Pubitemid 41407042)
16. Collins, F. S. (2004). Workshop summary: Direct to consumer advertising of genetic tests. Retrieved January 14, 2009, from http://www.genome.gov/ 12010660
17. Croyle, R. T., & Lerman, C. (1999). Risk communication in genetic testing for cancer susceptibility. Journal of the National Cancer Institute and Monograms, 25, 59-66.
18. DeLorme, D., Huh, J., & Reid, L. N. (2006). Age differences in how consumers behave following exposure to DTC advertising. Health Communication, 20, 255-265.
19. Desphpande, A., Menon, A., Perri III, M., & Zinkhan, G. (2004). Direct-to-consumer advertising and its utility in health care decision-making: A consumer perspective. Journal of Health Communication, 9, 499-513. (Pubitemid 40115879)
20. Evans, D. G., Shenton, A., Woodward, E., Lalloo, F., Howell, A., & Maher, E. R. (2008). Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast=ovarian cancer quoted should reflect cancer burden in the family. BMC Cancer, 8, 1-9.
21. Fraenkel, L., & McGraw, S. (2007). Participation in medical decision making: The patients' perspective. Medical Decision Making, 27, 533-540.
22. Freedman, T. G. (1998). Genetic susceptibility testing: Ethical and social quandaries. Health and Social Work, 23, 214-229.
23. Friedman, M., & Gould, J. (2007). Consumer attitudes and behaviors associated with directto- consumer prescription drug marketing. Journal of Consumer Marketing, 24, 100-109.
24. Geransar, R., & Einsiedel, E. (2008). Evaluating online direct-to-consumer marketing of genetic tests: Informed choices or buyers beware? Genetic Testing, 12, 13-24.
25. Gollust, S. E., Hull, S. C., & Wilfond, B. S. (2002). Limitations of direct-to-consumer advertising for clinical genetic testing. JAMA, 288, 1762-1767.
26. Gray, S., & Olopade, O. L. (2003). Direct-to-consumer marketing of genetic tests for cancer: Buyer beware. Journal of Clinical Oncology, 21, 3191-3194.
27. Gurmankin, A. D., Baron, J., Hershey, J. C., & Ubel, P. A. (2002). The role of physician's recommendations in medical treatment decisions. Medical Decision Making, 22, 262-271. (Pubitemid 34535325)
28. Gwyn, K., Vernon, S. W., & Conoley, P. M. (2003). Intention to pursue genetic testing for breast cancer among women due for screening mammography. Cancer Epidemiology, Biomarkers & Prevention, 12, 97-102.
29. Haas, J. S., Kaplan, C. P., Des Jarlais, G., Gildengoin, V., Perez-Stable, E. J., & Kerlikowske, K. (2005). Perceived risk of breast cancer among women at average and increased risk. Journal of Women's Health, 14, 845-851. (Pubitemid 43019896)
30. Hack, T. F., Degner, L. F., Watson, P., & Sinha, L. (2006). Do patients benefit from participating in medical decision-making? Longitudinal follow-up of women with breast cancer. Psycho-Oncology, 15, 9-19. (Pubitemid 43141514)
31. Hallowell, N., Foster, C., Eeles, R., Ardern-Jones, A., Murday, V., & Watson, M. (2003). Balancing autonomy and responsibility: The ethics of generating and disclosing genetic information. Journal of Medical Ethics, 29, 74-83.
32. Heshka, J., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. (2008). A Systematic review of perceived risks, psychological and behavioural impact of genetic testing. Genetic Medicine, 10, 19-32.
33. Hollon, M. F. (2005). Direct-to-consumer advertising: A haphazard approach to health promotion. Journal of the American Medical Association, 293, 2030-2033. (Pubitemid 40570899)
34. Kaplan, C. P., Haas, J. S., Perez-Stable, E. J., Gregorich, S. E., Somkin, C., Des Jarlasi, G., et al. (2006). Breast cancer risk reduction options: Awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiological Biomarkers Prevention, 15, 162-166.
35. Kausmeyer, D. T., Lengerich,E. J., Kluhsman, B. C.,Morrone,D.,Harper,G.R. ,&Baker,M. J. (2006). A survey of patients' experiences with the cancer genetic counseling process: Recommendations for cancer genetics program. Journal of Genetic Counseling, 15, 409-431. (Pubitemid 44900660)
36. Kiesler, D. J., & Auerbach, S. M. (2006). Optimal matches of patient preferences for information, decision-making, and interpersonal behavior: Evidence, models, and interventions. Patient Education and Counseling, 61, 319-341. (Pubitemid 43767441)
37. Kinney, A. Y., Croyle, R. T., Dudley, W. N., Bailey, C. A., Pelias, M. K., & Neuhausen, S. L. (2001). Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: A survey of a large African-American kindred with a BRCA1 mutation. Preventive Medicine: An International Journal Devoted to Practice and Theory, 33, 543-551. (Pubitemid 34101877)
38. Kravitz, R. L., & Melnikow, J. (2001). Engaging patients in medical decision making. BMJ, 323, 584-585. (Pubitemid 32846119)
39. Kremer, H., Ironson, G., Schniederman, N., & Hautzinger, M. (2007). "It's my body": Does patient involvement in decision-making reduce decisional conflict? Medical Decision Making, 27, 522-532. (Pubitemid 47547598)
40. Lerman, C., Daly, M., Sands, C., Balshern, A., Lustbader, E., Heggan, T., et al. (1993). Mammography adherence and psychological distress among women at risk for breast cancer. Journal of the National Cancer Institute, 85, 1074-1080. (Pubitemid 23199189)
41. Lerman, C., Schwartz, M. D., Lin, T. H., Hughes, C., Narod, S., & Lynch, H. (1997). The influence of psychological distress on use of genetic testing for cancer risk. Journal of Consulting and Clinical Psychology, 65, 414-420. (Pubitemid 27246782)
42. Lerman, C., Trock, B., Rimer, B. K., Boyce, A., Jepson, C., & Engstrom, P. F. (1991). Psychological and behavioral implications of abnormal mammograms. Annals of Internal Medicine, 114, 657-661.
43. Lux, M. P., Fasching, P. A., & Beckmann, M. W. (2006). Hereditary breast and ovarian cancer: Review and future perspectives. Journal of Molecular Medicine, 84, 16-28. (Pubitemid 43099520)
44. MacDonald, D. J., Sarna, L., Uman, G. C., Grant, M., & Weitzel, J. N. (2005). Health beliefs of women with and without breast cancer seeking genetic cancer risk assessment. Cancer Nursing, 28, 372-379.
45. Matloff, E., & Caplan, A. (2008). Direct to confusion: Lessons learned from marketing BRCA testing. American Journal of Bioethics, 8, 5-8.
46. Myers, M. F., Man-Huei, C., Jorgensen, C., Whitworth, W., Kassim, S., & Litch, J. A. (2006). Genetic testing for susceptibility to breast and ovarian: Evaluating the impact of a direct-to-consumer marketing campaign on physicans' knowledge and practices. Genetics in Medicine, 8, 361-370. (Pubitemid 44297307)
47. Myriad Genetics, Inc. (2007). Myriad Genetics launches awareness advertising campaign to educate women about hereditary risks of breast and ovarian cancers. Retrieved February 18, 2009, from http://investor.myriad.com/ releasedetail.cfm?ReleaseID=408932
48. National Cancer Institute, Breast Cancer Surveillance Consortium. (2008). Patient Information Form. Retrieved January 10, 2008, from http:// breastscreening.cancer.gov/ data/ptlong6.pdf
49. National Cancer Institute. (2008). Genetics of breast and ovarian cancer. Retrieved January 10, 2008, from http://www.cancer.gov/cancertopics/pdq/ genetics/breast-and-ovarian/ HealthProfessional
50. National Cancer Institute, Divison of Cancer Epidemiology and Genetics. (2008). Women's Health Study. Retrieved January 10, 2008, from http://dceg.cancer.gov/modules/ WomenHealth.pdf
51. National Comprehensive Cancer Network. (2007). Genetic=familial high-risk assessment: Breast and ovarian. Practice Guidelines in Oncology - V.1.2007. Retrieved October 15, 2007, from http://www.nccn.org/professionals/physician- gls/PDF/genetics-screening.pdf
52. National Human Genome Research Institute. (2004). Learning about breast cancer. Retrieved January 19, 2009, from http://www.genome.gov/12010660
53. Pasacreta, J. V. (2003). Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: An integrative review. Cancer Investigation, 21, 588-623. (Pubitemid 37169563)
54. Ries, L. A. G., Melbert, D., Krapcho, M., Stinchcomb, D. G., Howlader, N., Horner, M. J., et al. (2007). SEER cancer statistics review, 1975-2005. Bethesda, MD: National Cancer Institute. Retrieved January 10, 2009 from http://seer.cancer.gov/csr/1975-2005
55. Robinson, A. R., Hohmann, K. B., Rifkin, J. I., Topp, D., Gilroy, C. M., Pickard, J. A., et al. (2004). Direct-to-consumer pharmaceutical advertising. Physician and public opinion and potential effects on the physician-patient relationship. Archives of Internal Medicine, 164, 427-432. (Pubitemid 38240707)
56. Say, R., Murtagh, M., & Thomson, R. (2006). Patients' preference for involvement in medical decision making: A narrative review. Patient Education and Counseling, 60, 102-114. (Pubitemid 43143304)
57. Scantron Corporation. (n.d.). Retrieved April 1, 2009, from http://www.scantron.com/ eListen
58. Shiloh, S., & Ilan, S. (2005). To test or not to test? Moderators of the relationship between risk perceptions and interest in predictive genetic testing. Journal of Behavioral Medicine, 28, 467-477.
59. Singh, J., Cutler, L., & Silvers, J. B. (2004). Toward understanding consumers' roles in medical decisions for emerging treatments: Issues, framework, and hypotheses. Journal of Business Research, 57, 1054-1065. (Pubitemid 39072435)
60. Singh, T., & Smith, D. (2005). Direct-to-consumer prescription drug advertising: A study of consumer attitudes and behavioral intentions. Journal of Consumer Marketing, 22, 369-378. (Pubitemid 41766476)
61. Smith, K. L., & Isaacs, C. (2007). Management of women at increased risk for hereditary breast cancer. Breast Disease, 27, 51-67. (Pubitemid 47555189)
62. Somers, T. J., Michael, J. C., Klein, W. M. P., & Baum, A. (2009). Cancer genetics service interest in women with a limited family history of breast cancer. Journal of Genetic Counseling, 18, 339-349.
63. Sumpradit, N., Fors, S. W., & McCormick, L. (2002). Consumer's attitudes and behaviors towards prescription drug advertising. American Journal of Health Behavior, 26, 68-75.
64. Thompson, S. C., Pitts, J. S., & Schwankovsky, L. (1993). Preferences for involvement in medical decision-making: Situational and demographic influences. Patient Education and Counseling, 22, 133-140. (Pubitemid 24069433)
65. U.S. Preventive Services Task Force. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Annals of Internal Medicine, 143, 355-361.
66. Wang, C., Gonzalez, R., Janz, N. K., Milliron, K. J., & Merajver, S. D. (2007). The role of cognitive appraisal and worry in BRCA1=2 testing decisions among a clinic population. Psychology & Health, 22, 719-736.
67. Welch Cline, R. J., & Young, H. N. (2005). Direct-to-consumer print ads for drugs: Do they undermine the physician-patient relationship? The Journal of Family Practice, 54, 1049-1057. (Pubitemid 43116596)
68. Williams-Jones, B. (2006). Be ready against cancer, now: Direct-to-consumer advertising for genetic testing. New Genetics and Society, 25, 90-107.
69. Wolfberg, A. J. (2007). Genes on the Web-Direct to consumer marketing of genetic testing. New England Journal of Medicine, 355, 543-544.
70. Young, H. N., & Welch Cline, R. J. (2005). Textual cues in direct-to-consumer prescription drug advertising: Motivators to communicate with physicians. Journal of Applied Communication Research, 33, 348-369. (Pubitemid 41681081)